University of Pennsylvania Abramson Cancer Center — Philadelphia, Pennsylvania

Public research footprint of University of Pennsylvania Abramson Cancer Center, compiled from the ClinicalTrials.gov public registry.

331

Registered studies

159

Active

Recruiting now

125

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage II Lung Non-Small Cell Cancer AJCC v7 · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma

Recently updated registry entries

NCT04527549 — Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV… (Terminated)
NCT03253848 — Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute… (Active Not Recruiting)
NCT03419234 — Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Pennsylvania Abramson Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.